Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01736865 · ClinicalTrials.gov registry record · Phase 2
Vitamin D for Established Type 2 Diabetes (DDM2)
A Phase 2 study, sponsored by Tufts Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 127
- Enrollment target
NCT01736865 is a Phase 2 study that has completed, run by Tufts Medical Center. The registered enrollment target is 127 participants.
The verdict
NCT01736865, a Phase 2 study, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 127 participants
- Enrollment target
Study Summary
This research study in adults with established type 2 diabetes will test whether daily vitamin D supplementation affects how the body processes glucose (sugar).
Interventions
- DRUG Placebo
- DRUG Cholecalciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2012-12 |
| Est. Completion | 2015-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01736865
The ClinicalTrials.gov registry entry for NCT01736865 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 127 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01736865 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01736865 about?
NCT01736865 is a clinical study titled "Vitamin D for Established Type 2 Diabetes (DDM2)". This research study in adults with established type 2 diabetes will test whether daily vitamin D supplementation affects how the body processes glucose (sugar).
What is the current status of trial NCT01736865?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 127 participants. The study started on 2012-12. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01736865?
The interventions under investigation include: Placebo (DRUG), Cholecalciferol (DRUG).
Who is sponsoring clinical trial NCT01736865?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.